Your daily dose of the clinical news you may have missed.
Sydney Jennings
Advertisement
Sydney Jennings is the editor of Patient Care Online. She joined MJH Life Sciences in March 2018 after graduating from the University of Connecticut with a BA in Journalism. She can be reached at [email protected].
Articles by Sydney Jennings
From ACIP updates on age eligibility and research on vaccine efficacy to US adults' attitudes toward recommended shots, these 10 at-a-glance news briefs are must-reads for PCPs.
Your daily dose of the clinical news you may have missed.
Nemolizumab is the first approved monoclonal antibody that targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives disease mechanism in atopic dermatitis.
Find details on US colorectal cancer screening rates, dietary interventions for people with IBS, and research on the primary drivers of cost of IBD care.
Your daily dose of the clinical news you may have missed.
Intra-Cellular Therapies submitted an sNDA to the FDA for lumateperone for the treatment of MDD in adults as as adjunctive therapy to antidepressants.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
The Prescription Drug User Fee Act date is set for May 7, 2025.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Many unvaccinated adults reported intent to get vaccinated, according to early season estimates released in MMWR.
Your daily dose of the clinical news you may have missed.
In a study of adults enrolled in a telehealth weight management program, 45% decreased their alcohol use after taking antiobesity medication.
Your daily dose of the clinical news you may have missed.
Review authors emphasized the need for a more comprehensive approach to dementia management.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
The investigational weight loss drug showed substantial weight loss among people with obesity or overweight with or without T2D without plateaus.
Comments on the draft recommendation can be submitted through December 23, 2024.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Newer GLP-1 Therapies Linked to Fewer Alcohol-Related Hospitalizations in Adults With AUD
2
Compulsive Smartphone Use Linked to Depressive Symptoms in Older Adults
3
2026 Dyslipidemia Guideline Expands Statin Eligibility to 21.5 Million More US Adults
4
Early Liver Disease Detection Starts in Primary Care: A Q&A With Stevan Gonzalez, MD
5